VSTM
NASDAQ · Biotechnology
Verastem Inc
$5.18
+0.25 (+5.07%)
Open$5.03
Previous Close$4.93
Day High$5.22
Day Low$4.97
52W High$11.25
52W Low$4.01
Volume—
Avg Volume1.57M
Market Cap517.72M
P/E Ratio—
EPS$-3.06
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+171.2% upside
Current
$5.18
$5.18
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 24.20M | 14.27M | 326.86M |
| Net Income | -316,163,443 | -167,775,411 | 9.66M |
| Profit Margin | -1,306.4% | -1,241.1% | 3.0% |
| EBITDA | -314,650,906 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +69.6% | +69.6% | +8.0% |
| Debt/Equity | 0.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |